menu
    • menu

    Company profile for Nanoscope Therapeutics

    NEW Drugs in Dev: 5
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight to the millions of blind individuals suffering from retinal degenerative disease, for which no cure exists. We utilize ambient light-sensitive molecule to re-senitize the retina toward low light level. Our light-assisted gene therapy is highly targeted to geographic atrophies without perturbing t...
    Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight to the millions of blind individuals suffering from retinal degenerative disease, for which no cure exists. We utilize ambient light-sensitive molecule to re-senitize the retina toward low light level. Our light-assisted gene therapy is highly targeted to geographic atrophies without perturbing the intact retina circuitry. Our team is highly experienced in Ophthalmology product development and clinical translation of innovative research.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Nanoscope TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1312 Brown Trail Suite A Bedford, TX 76022
    Telephone
    Telephone
    (817) 719-2692
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://nanostherapeutics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Nanoscope Gets Japan MHLW Sakigake & Orphan Drug Status
    Nanoscope Gets Japan MHLW Sakigake & Orphan Drug Status

    20 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/nanoscope-secures-japan-mhlw-sakigake-and-orphan-drug-designations-across-inherited-retinal-diseases--a-first-for-a-retinal-gene-therapy-302664876.html

    PR NEWSWIRE
    20 Jan 2026
    Share Share
    Nanoscope Secures U.S. Patent for Opsin Vision Platform
    Nanoscope Secures U.S. Patent for Opsin Vision Platform

    07 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/nanoscope-therapeutics-granted-new-us-patent-covering-its-proprietary-multi-characteristic-opsin-platform-for-vision-restoration-302655126.html

    PR NEWSWIRE
    07 Jan 2026
    Share Share
    Nanoscope Presents at 44th JP Morgan Healthcare Conference
    Nanoscope Presents at 44th JP Morgan Healthcare Conference

    05 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/nanoscope-therapeutics-to-present-at-the-44th-annual-jp-morgan-healthcare-conference-302652272.html

    PR NEWSWIRE
    05 Jan 2026
    Share Share
    Nanoscope Therapeutics Showcased In Multiple Advanced Therapies
    Nanoscope Therapeutics Showcased In Multiple Advanced Therapies

    17 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/nanoscope-therapeutics-featured-in-multiple-presentations-at-advanced-therapies-usa-2025-302616472.html

    PR NEWSWIRE
    17 Nov 2025
    Share Share
    Nanoscope Reports 5-Year Safety From Ph 1/2a MCO-010 RP Study
    Nanoscope Reports 5-Year Safety From Ph 1/2a MCO-010 RP Study

    04 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/nanoscope-therapeutics-reports-five-year-safety-results-from-phase-12a-follow-up-study-of-mco-010-optogenetic-therapy-in-retinitis-pigmentosa-302603355.html

    PR NEWSWIRE
    04 Nov 2025
    Share Share
    Nanoscope Secures FDA RMAT, EMA Orphan Designations For MCO-010
    Nanoscope Secures FDA RMAT, EMA Orphan Designations For MCO-010

    02 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/nanoscope-strengthens-global-regulatory-pathways-for-mco-010-with-fda-rmat-and-five-ema-orphan-designations-302543344.html

    PR NEWSWIRE
    02 Sep 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search